• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov18
Evercore ISI Analyst Maintains Buy Rating on Edgewise Therapeutics
10:42
Nov14
JP Morgan Raises Target Price, Driving Edgewise Therapeutics Stock Up
17:29
Nov13
Piper Sandler Analyst Maintains Buy Rating for Edgewise Therapeutics
11:52
Nov7
H.C. Wainwright Reiterates Buy Rating on Edgewise Therapeutics
12:02
Nov6
Edgewise Therapeutics released FY2025 Q3 earnings on November 6, Pre-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.39 (forecast USD -0.3932)
14:30
Edgewise Therapeutics released FY2025 9 Months Earnings on November 6 Pre-Market EST, actual revenue USD 0, actual EPS USD -1.1584
14:30

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -40.67 M, EPS -0.3854

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -36.12 M, EPS -0.3441

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -40.8 M, EPS -0.4288

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0493
+77.34%
+0.021
FOXX
3.540
+75.16%
+1.519
PTN
22.820
+57.49%
+8.330
MNDR
4.750
+56.25%
+1.710
NVVE
0.2558
+55.88%
+0.092
DVLT
2.550
+46.55%
+0.810
CCTG
0.2364
+43.01%
+0.071
IVDA
0.8760
+34.67%
+0.226
BLMZ
1.000
+30.55%
+0.234
ALPS
1.180
+29.56%
+0.269
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy